Fitch: Bristol-Myers Squibb's Ratings Unlikely to be Affected by Mead Johnson Spin-off.
Business Wire › November 16, 2009
Linked as:
Extract
Fitch: Bristol-Myers Squibb's Ratings Unlikely to be Affected by Mead Johnson Spin-off.
CHICAGO -- Fitch Ratings does not expect Bristol-Myers Squibb Co.'s (Bristol-Myers Squibb) announced spin-off of its remaining ownership in Mead Johnson Nutrition Co. (Mead Johnson) to have a material impact o...
See the full content of this document
Sponsored links
